Subject: RE: Test
From: Kim Matthis <[email-masked]>
To: Ketevan Goginashvili <[email-masked]>
Date: Tue, 09 Jun 2020 09:33:12 +0000

Dear Keti,

Many thanks for your email and your valuable input. Would you be ok then that we update the budget with
COVID19-Ag rapid tests instead as WHO recommendation is
that IgG/lgM is to be only used serosurveillance studies? Please let me know what you think.

All the best,

Kim

From: Ketevan Goginashvili

Sent: 09 June 2020 13:19

To: Kim Matthis

Subject: RE: Test

CAUTION: This email originated from outside of the organization. Please do not click links or open attachments unless you recognize the source of this email and know the content is safe.

Dear Kim,

Thank you for your attention and support.

According to the laboratory testing algorithm (Ministerial decree N01-144/o  01.04.2020), laboratories use COVID19-Ag rapid tests (cost per unit $15 by WHO) and COVID19- IgG/lgM Tests to diagnose
covid-19.

With best regards, Keti

From: Kim Matthis [mailto:[email-masked]]

Sent: 9 June, 2020 11:16

To: Ketevan Goginashvili <[email-masked]>

Subject: Test

Dear Keti,

Just following up on our conversation this morning as we understand that the IgG/lgM test are only
recommended for serosurveillance studies. If you could provide me with another test type or two as well as cost/test, that would be great. This is the last piece of information I would need from my side before I will send you the budget again
for review and ask you to fill in a few last documents needed for contracting.

All the best,

Kim

This email was scanned by Bitdefender